The_DT
ability_NN
of_IN
BHRF1_NN
to_TO
inhibit_VB
apoptosis_NN
is_VBZ
dependent_JJ
on_IN
stimulus_NN
and_CC
cell_NN
type_NN
._.

The_DT
development_NN
of_IN
resistance_NN
to_TO
host_NN
defense_NN
mechanisms_NNS
such_JJ
as_IN
tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
-_:
and_CC
Fas-mediated_JJ
apoptosis_NN
of_IN
transformed_VBN
or_CC
virus-infected_JJ
cells_NNS
may_MD
be_VB
a_DT
critical_JJ
component_NN
in_IN
the_DT
development_NN
of_IN
disease_NN
._.

To_TO
find_VB
genes_NNS
that_WDT
protect_VBP
cells_NNS
from_IN
apoptosis_NN
,_,
we_PRP
used_VBD
an_DT
expression_NN
cloning_NN
strategy_NN
and_CC
identified_VBD
BHRF1_NN
,_,
an_DT
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
early-lytic-cycle_JJ
protein_NN
with_IN
distant_JJ
homology_NN
to_TO
Bcl-2_NN
,_,
as_IN
an_DT
anti-apoptosis_JJ
protein_NN
._.

Expression_NN
of_IN
BHRF1_NN
in_IN
MCF-Fas_NN
cells_NNS
conferred_VBD
nearly_RB
complete_JJ
resistance_NN
against_IN
both_CC
anti-Fas_JJ
antibody_NN
and_CC
TNF-mediated_JJ
apoptosis_NN
._.

In_IN
addition_NN
,_,
BHRF1_NN
protected_VBD
these_DT
cells_NNS
from_IN
monocyte-mediated_JJ
killing_NN
but_CC
failed_VBD
to_TO
protect_VB
them_PRP
from_IN
killing_NN
mediated_VBN
by_IN
lymphokine-activated_JJ
killer_NN
cells_NNS
._.

The_DT
ability_NN
of_IN
BHRF1_NN
to_TO
protect_VB
MCF-Fas_NN
cells_NNS
from_IN
apoptosis_NN
induced_VBN
by_IN
various_JJ
stimuli_NNS
was_VBD
identical_JJ
to_TO
that_DT
of_IN
Bcl-2_NN
and_CC
Bcl-xL_NN
._.

Moreover_RB
,_,
the_DT
mechanism_NN
of_IN
action_NN
of_IN
BHRF1_NN
resembled_VBD
that_DT
of_IN
Bcl-2_NN
and_CC
Bcl-xL_NN
as_IN
it_PRP
inhibited_VBD
TNF_NN
-_:
and_CC
anti-Fas-induced_JJ
activation_NN
of_IN
two_CD
enzymes_NNS
participating_VBG
in_IN
the_DT
apoptosis_NN
pathway_NN
,_,
cytosolic_JJ
phospholipase_NN
A2_NN
and_CC
caspase-3_NN
\/_:
CPP32_NN
,_,
but_CC
did_VBD
not_RB
interfere_VB
with_IN
the_DT
activation_NN
of_IN
NF-kappaB-like_JJ
transcription_NN
factors_NNS
._.

A_DT
putative_JJ
function_NN
of_IN
BHRF1_NN
in_IN
EBV-infected_JJ
epithelial_JJ
cells_NNS
may_MD
be_VB
to_TO
protect_VB
virus-infected_JJ
cells_NNS
from_IN
TNF_NN
-_:
and\/or_CC
anti-Fas-induced_JJ
cell_NN
death_NN
in_IN
order_NN
to_TO
maximize_VB
virus_NN
production_NN
._.

Surprisingly_RB
,_,
expression_NN
of_IN
neither_CC
BHRF1_NN
nor_CC
Bcl-2_NN
in_IN
a_DT
B-cell_NN
line_NN
,_,
BJAB_NN
,_,
protected_VBD
the_DT
cells_NNS
from_IN
anti-Fas-mediated_JJ
apoptosis_NN
even_RB
though_IN
they_PRP
increased_VBD
the_DT
survival_NN
of_IN
serum-starved_JJ
cells_NNS
._.

Thus_RB
,_,
the_DT
protective_JJ
role_NN
of_IN
BHRF1_NN
against_IN
apoptosis_NN
resembles_VBZ
that_DT
of_IN
Bcl-2_NN
in_IN
being_VBG
cell_NN
type_NN
specific_JJ
and_CC
dependent_JJ
on_IN
the_DT
apoptotic_JJ
stimulus_NN
._.

